Matrix Metalloproteinase Activity Modulates Tumor Size, Cell Motility, and Cell Invasiveness in Murine Aggressive Fibromatosis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Research

• Publication date

  2004-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-03-3112PMID 15313922
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BMC Developmental Biology BioMed Central Research article

  2003cited by this paper
• Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor)

  2003cited by this paper
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry

  2003cited by this paper
• Stromelysin-1 and mesothelin are differentially regulated by Wnt-5a and Wnt-1 in C57mg mouse mammary epithelial cells

  2003cited by this paper
• Tumor formation by genetic mutations in the components of the Wnt signaling pathway

  2003cited by this paper
• Matrix metalloproteinases in tumor-host cell communication.

  2002cited by this paper
• Matrix metalloproteinases in cancer.

  2002cited by this paper
• Strategies for MMP inhibition in cancer: innovations for the post-trial era

  2002cited by this paper
• The Promise and Perils of Wnt Signaling Through β-Catenin

  2002cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• β-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds

  2002cited by this paper
• Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells.

  2002cited by this paper
• Linking β-Catenin to Androgen-signaling Pathway*

  2002cited by this paper
• The promise and perils of Wnt signaling through beta-catenin.

  2002cited by this paper
• Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

  2002cited by this paper
• Matrix metalloproteinases and collagen catabolism.

  2002cited by this paper
• Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells.

  2002cited by this paper
• Identification of membrane-type matrix metalloproteinase-1 as a target of the β-catenin/Tcf4 complex in human colorectal cancers

  2002cited by this paper
• Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor)

  2001influential reference
• Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis

  2001cited by this paper
• Desmoid tumours.

  2001cited by this paper
• Curbing the nuclear activities of beta-catenin. Control over Wnt target gene expression.

  2000cited by this paper
• The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter

  2000cited by this paper
• Catenins, Wnt signaling and cancer.

  2000cited by this paper
• Curbing the nuclear activities of β‐catenin

  2000cited by this paper
• Wnt signaling and cancer.

  2000cited by this paper
• Control over Wnt target gene expression

  2000cited by this paper
• Enzymatic quantification of cell-matrix and cell-cell adhesion.

  2000cited by this paper
• Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)

  1999cited by this paper
• β-Catenin Regulates the Expression of the Matrix Metalloproteinase-7 in Human Colorectal Cancer

  1999cited by this paper
• beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.

  1999cited by this paper
• The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors

  1999cited by this paper
• Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.

  1998cited by this paper
• Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis

  1998cited by this paper
• Adenomatous Polyposis Coli Gene Mutation Alters Proliferation through its β-Catenin-Regulatory Function in Aggressive Fibromatosis (Desmoid Tumor)

  1998cited by this paper
• Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts.

  1998influential reference
• Analysis of apoptosis by flow cytometry.

  1998cited by this paper
• Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor).

  1998cited by this paper
• Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).

  1997cited by this paper
• Aggressive Fibromatosis (Desmoid Tumor) is A Monoclonal Disorder

  1997cited by this paper
• Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.

  1997cited by this paper
• Intestinal and extra-intestinal tumor multiplicities in the Apc1638N mouse model after exposure to X-rays.

  1997cited by this paper
• Desmoid fibromatosis is a clonal process.

  1996cited by this paper
• Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation.

  1996cited by this paper
• Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice.

  1996cited by this paper
• Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.

  1995cited by this paper
• Platelet‐derived growth factor in fibrous musculoskeletal disorders: A study of pathologic tissue sections and in vitro primary cell cultures

  1995cited by this paper
• Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1.

  1995cited by this paper
• Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures.

  1994cited by this paper
• Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat.

  1994cited by this paper
• Matrix metalloproteinases: a review.

  1993cited by this paper
• Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases.

  1992cited by this paper
• Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serum

  1992cited by this paper
• Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins.

  1991cited by this paper
• Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

  1991cited by this paper
• Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes.

  1987cited by this paper

• The Notch signaling pathway in desmoid tumor: Recent advances and the therapeutic prospects.

  2023cites this paper
• Molecular Pathogenesis of Sporadic Desmoid Tumours and Its Implications for Novel Therapies: A Systematised Narrative Review

  2022cites this paper
• [Biology and signaling pathways involved in the oncogenesis of desmoid tumors].

  2020cites this paper
• Activated Signaling Pathways and Targeted Therapies in Desmoid-Type Fibromatosis: A Literature Review

  2019influential citation
• Intratumoral fate of functional nanoparticles in response to microenvironment factor: Implications on cancer diagnosis and therapy.

  2019cites this paper
• Rare Tumors in Pediatric Oncology

  2018cites this paper
• Comparative transcriptomic profiling of hydrogen peroxide signaling networks in zebrafish and human keratinocytes: Implications toward conservation, migration and wound healing

  2016cites this paper
• Juvenile Aggressive Fibromatosis – Review Of Literature

  2015cites this paper
• MicroRNAs in the Regulation of MMPs and Metastasis

  2014cites this paper
• TIMP-1 modulates chemotaxis of human neural stem cells through CD63 and integrin signalling.

  2014cites this paper
• Desmoid tumors of the head and neck: A therapeutic challenge

  2014cites this paper
• A Regulatory Loop between β-Catenin and Extra-cellular Matrix Components during the Proliferative Phase of Cutaneous Wound Healing

  2014cites this paper
• Fibroblastic tumors of intermediate malignancy in childhood

  2013cites this paper
• &bgr;-Catenin and matrix metalloproteinase-7 expression in deep fibromatosis: impact on the local recurrence

  2012cites this paper
• Experimental Approaches for Understanding the Role of Matrix Metalloproteinases in Cancer Invasion

  2012cites this paper
• Extra-Abdominal Desmoid Tumours: A Review of the Literature

  2012cites this paper
• Identifying Pharmacological Therapeutics for Aggressive Fibromatosis

  2011cites this paper
• Matrix metalloproteinases and their clinical relevance in urinary bladder cancer

  2011cites this paper
• Aggressive fibromatosis in children: a changing approach.

  2011cites this paper
• Clonal complex chromosome aberration in non‐ossifying fibroma

  2010cites this paper
• Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells.

  2010cites this paper
• Desmoid tumors: need for an individualized approach

  2009cites this paper
• FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin

  2009cites this paper
• TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro

  2009cites this paper
• Musculoskeletal desmoid tumors.

  2008cites this paper
• [Therapeutic options for aggressive fibromatosis].

  2008cites this paper
• Therapieoptionen bei der aggressiven Fibromatose

  2008cites this paper
• The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis

  2008cites this paper
• Gene Translocations in Musculoskeletal Neoplasms

  2008cites this paper
• TIMPs: Extracellular Modifiers in Cancer Development

  2008cites this paper
• Inhibition of notch signaling induces neural differentiation in Ewing sarcoma.

  2007cites this paper
• Opportunities for improving the therapeutic ratio for patients with sarcoma.

  2007cites this paper
• IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors.

  2007cites this paper
• Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.

  2007cites this paper
• Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse

  2007cites this paper
• Gelatinase A activity in Dupuytren's disease.

  2006cites this paper
• Beta‐catenin regulates wound size and mediates the effect of TGF‐beta in cutaneous healing

  2006cites this paper
• Inhibitory and Stimulatory Bystander Effects are Differentially Induced by Iodine-125 and Iodine-123

  2006cites this paper
• Matrix metalloproteinases and tumor metastasis

  2006cites this paper
• Fibrous and Fibrohistiocytic Tumors

  2006cites this paper
• Desmoid tumors and current status of management.

  2006cites this paper
• Plasminogen activator inhibitor-1 (PAI-1) modifies the formation of aggressive fibromatosis (desmoid tumor)

  2005cites this paper
• New roles for matrix metalloproteinases in metastasis.

  2005cites this paper